Navigation Links
PARI Respiratory Equipment Featured on Oxygen Network
Date:9/5/2008

MIDLOTHIAN, Va., Sept. 5 /PRNewswire/ -- On Saturday, September 6, PARI Respiratory Equipment will be featured on the Oxygen Network show Today's Family as part of their "Breathe Easier" series. PARI is highlighted as a leading medical device company that provides patients, such as COPD sufferers, with effective nebulizers and compressors that deliver needed medications directly to the lungs.

"Our vision is to improve the lives of those affected by respiratory diseases and those who care for them. This is an excellent opportunity for patients and family members to learn more about current respiratory delivery devices that help treat diseases such as COPD and asthma," said Geoff A. Hunziker, President of PARI Respiratory Equipment, Inc.

Viewers can watch the segment on the Oxygen Network on September 6 at 6am Eastern, 6am Pacific, 5am Central, 4am Mountain Time. ABC Family will also air the respiratory-focused show later in the month.

Chronic obstructive pulmonary disease, also known as COPD, is the fourth leading cause of death in America, behind heart disease, cancer, and stroke. It is estimated that approximately 12 million Americans have been diagnosed with the disease, and at least another 12 million have symptoms, but have not been diagnosed.

Recently, 2 new medications have been approved for COPD symptoms, one from Sepracor (Brovana) and one from Dey LP (Perforomist). Both products used PARI Nebulizers exclusively in all the pivotal clinical trials that proved safety and efficacy. These companies chose PARI products based on PARI's long track record of clinical trial experience.

About PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.

Mak
'/>"/>

SOURCE PARI Respiratory Equipment, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
4. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
5. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
6. Fire Season: Respiratory Health a Concern
7. Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities
8. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
9. Recently discovered virus associated with pediatric respiratory tract infection in Germany
10. New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD
11. Kids Respiratory Virus Season Off and Running
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... risk may not be accurate in some cases , ...es, from the United States and the Netherlands, qu...hed Framingham Risk Score in predicting heart dise...score, based on findings of a decades-long study i...assess risk on the basis of seven factors: age, ge...
(Date:1/8/2009)...iday, January 9 , , WASHINGTON, Jan. 8 /PRNews...rnational Union (SEIU) President Andy Stern conven...cutive Board to discuss the forced transfer of 65,...United Healthcare Workers-West (UHW), its third la...til tomorrow. , , According to reports, several...
(Date:1/8/2009)...ey Factor in Decision for Florida Multi-Specialty ...RNewswire-FirstCall/ -- Allscripts announced today... multi-specialty group practices in the Southeast ...ise(TM) Electronic Health Record (EHR) to automate...oss Central Florida. , , (Logo: http://www.n...
(Date:1/8/2009)...-FirstCall/ -- Hanger Orthopedic Group, Inc. (NYSE...he fourth quarter of 2008 it acquired Maine Artifi...thotic-Prosthetics Center, Riessen,s Orthopedic an... & Prosthetics, and Orthopedic Rehabilitation ... centers to existing markets in Maine, Louisiana, ...
Breaking Medicine News(10 mins):Health News:Studies Challenge Framingham Risk Score 2Health News:Studies Challenge Framingham Risk Score 3Health News:SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2
...ne specialists have developed a tool to help hospi...verwhelm services//. The Electronic Mass Casualty ...program calculates the impact of such crises as a ...od or plane crash, accounting for such elements as...
...en than we think, but it is also more treatable th.../. Children and adolescents should be monitored ca...nly strike young adults often has its roots in chi...ly and all too often manifests its presence only w...
...to hide their pregnancies or even convince themsel...ot be getting// the psychiatric care they need, ac...han 30,000 birth records at a Midwestern urban hos...f Case Western Reserve University, and colleagues ...
...and arthritis are among a variety of autoimmune di...blood cell, called the immune regulatory// cell, m...ion is when a mutation in the FOXP3 gene disables ...tudy published online this week in the Proceedings...
Other Medicine News:Health News:Kidney Disease In Children: Common but Treatable 2Health News:Women Who Deny or Hide Pregnancies Get Little Psychiatric Care 2Health News:Researchers Discover New Molecular Path to Fight Autoimmune Diseases 2
(Date:1/6/2009)...ts from prior U.S., U.K. and China Trials , , S...Inc. (VTI), a development stage company targeting ...has begun for a randomized, controlled, multi-cent...racorporeal Liver Assist Device (ELAD) as a treatm...der three protocols. The study is open for enrollm...
(Date:1/6/2009)...e/ -- Cequent Pharmaceuticals, a pioneer in the de...treatments to prevent and treat human disease, ann...uccessful toxicology study of its candidate CEQ501...eting the primary oncogene (beta-catenin, CTNNB1) ... inherited gastrointestinal disease that causes hu...
(Date:1/5/2009)...swire/ -- Women undergoing in vitro,fertilization...port early,pregnancy, but the intramuscular injec...inful for patients. Formulations of progesterone ...ous injection or vaginal suppository may offer,si... With patient well-being a constant focus, Fert...
(Date:12/27/2008)...ewswire/ -- According to the latest,science, resv...est doses of,resveratrol plus an array of antioxi...asses of aged, red wine, rather than resveratrol a...i-bin/prnh/20080603/LATU039 ) , The most r...s to prolong,the life of laboratory mice. In fac...
Breaking Medicine Technology:ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3IMTEC Introduces the SPRITE CT System 21584 1IMTEC Introduces the SPRITE CT System 21584 2HMS Holdings Corp to Present at Jefferies 2nd Annual Healthcare Conference 21582 1COSE Introduces Health Incentives Wellness Programs for Medium Size Businesses 21580 1COSE Introduces Health Incentives Wellness Programs for Medium Size Businesses 21580 2Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 1Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 2Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 3Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 4Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 5
...gression-free survival in,the SPARC Phase 3 trial ...isk of disease progression for patients receiving,...e use,geographies, as well as presence or absence...tCall/ -- Pharmion,Corporation and GPC Biotech AG ...a from the double-blind, randomized satraplatin Ph...
...ts EORTC 40983 (EPOC),Intergroup Study Results, CH...ults of the,randomized phase III EORTC 40983 Inter...rst time that peri-operative (pre and post,surgery...combination with a standard chemotherapy regimen f...V)) given to patients with,resectable liver metast...
Other Medicine Technology:Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 2The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 3The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 6The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 8The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 9
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: